Search

everythinglearnresearchcommunity

for

Search:↓

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

Anabolic steroids and SARMs can cause serious liver damage.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Dutasteride and finasteride affect different cell types differently.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.

Male pattern baldness may predict prostate cancer risk.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.